During the evolution of flowering plants, their sperm cells have lost mobility and are transported from the stigma to the female gametophyte via the pollen tube to achieve double fertilization. Pollen tube growth and guidance is largely governed by the maternal sporophytic tissues of the stigma, style and ovule. However, the last phase of the pollen tube path is under female gametophyte control and is expected to require extensive cell-cell communication events between both gametophytes. Until recently, little was known about the molecules produced by the female gametophyte that are involved in this process. In the present paper, we review the most recent development in this field and focus on the role of secreted candidate signalling ligands.
The egg apparatus-secreted polymorphic EA1 peptide is required for micropylar pollen tube (PT) guidance in maize, the last step of the PT journey during the double fertilization process in flowering plants. In a recent study we have shown that maize PTs are attracted in vitro by EA1 and that their growth is arrested at high peptide concentrations. Moreover, we have also shown that maize PTs are guided in vitro in a species-preferential manner to the micropylar opening of transgenic Arabidopsis ovules secreting the EA1-GFP fusion protein. In support of these findings, we have improved the ligand-receptor labeling assay and report here that the EA1 peptide interacts in vitro with the maize PT apex in a species-specific manner. Bound peptide gets internalized in large vesicles and is degraded. This finding indicates that the pollen tube remains sensitive to the attractant by its rapid internalization.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.